[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,274,131
  • Shares Outstanding, K 22,851
  • Annual Sales, $ 249,600 K
  • Annual Income, $ 57,730 K
  • EBIT $ 73 M
  • EBITDA $ 84 M
  • 60-Month Beta 0.60
  • Price/Sales 9.29
  • Price/Cash Flow 34.95
  • Price/Book 5.70

Options Overview Details

View History
  • Implied Volatility 27.34% (-1.27%)
  • Historical Volatility 35.31%
  • IV Percentile 13%
  • IV Rank 24.43%
  • IV High 44.05% on 11/06/25
  • IV Low 21.93% on 09/02/25
  • Expected Move (DTE 27) 1.98 (2.02%)
  • Put/Call Vol Ratio 1.50
  • Today's Volume 5
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 3.88
  • Today's Open Interest 366
  • Open Int (30-Day) 349
  • Expected Range 95.83 to 99.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.81
  • Number of Estimates 2
  • High Estimate $0.81
  • Low Estimate $0.80
  • Prior Year $0.60
  • Growth Rate Est. (year over year) +35.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.46 +2.44%
on 05/13/26
115.95 -15.66%
on 04/27/26
-15.01 (-13.31%)
since 04/22/26
3-Month
88.35 +10.69%
on 02/25/26
118.01 -17.13%
on 04/14/26
+4.85 (+5.22%)
since 02/20/26
52-Week
78.35 +24.81%
on 05/23/25
118.01 -17.13%
on 04/14/26
+18.67 (+23.60%)
since 05/22/25

Most Recent Stories

More News
1 Reason to Avoid LMAT and 1 Stock to Buy Instead

1 Reason to Avoid LMAT and 1 Stock to Buy Instead

LMAT : 97.97 (-1.56%)
LeMaitre to Participate at Upcoming Investor Conferences in June

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies...

LMAT : 97.97 (-1.56%)
Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

LMAT : 97.97 (-1.56%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

LMAT : 97.97 (-1.56%)
BKD : 13.27 (-0.82%)
NVST : 23.60 (-0.13%)
5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call

5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call

LMAT : 97.97 (-1.56%)
LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May...

LMAT : 97.97 (-1.56%)
1 High-Flying Stock with Impressive Fundamentals and 2 We Avoid

1 High-Flying Stock with Impressive Fundamentals and 2 We Avoid

DCO : 143.87 (+0.66%)
AMSC : 51.70 (+4.61%)
LMAT : 97.97 (-1.56%)
LMAT Q1 Deep Dive: Artegraft Expansion and Pricing Drive, Margin Upside Meets Cautious Market

LMAT Q1 Deep Dive: Artegraft Expansion and Pricing Drive, Margin Upside Meets Cautious Market

LMAT : 97.97 (-1.56%)
LeMaitre: Q1 Earnings Snapshot

LeMaitre: Q1 Earnings Snapshot

LMAT : 97.97 (-1.56%)
LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates

LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates

LMAT : 97.97 (-1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and...

See More

Key Turning Points

3rd Resistance Point 103.19
2nd Resistance Point 102.10
1st Resistance Point 100.81
Last Price 97.97
1st Support Level 98.43
2nd Support Level 97.34
3rd Support Level 96.05

See More

52-Week High 118.01
Fibonacci 61.8% 102.86
Fibonacci 50% 98.18
Last Price 97.97
Fibonacci 38.2% 93.50
52-Week Low 78.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.